Search research articles
Contact Us
Filters
Showing results (51-60 of 420) with videos related to
Page
of 42
Sort By:
Infection Control and Hospital Epidemiology
|
August 7, 2013
The environment and healthcare-acquired infections: why accurate reporting and evaluation of biological plausibility are important
Stephan Harbarth, Matthias Maiwald, Stephanie J Dancer
Revue Medicale Suisse
|
December 5, 2013
[Procalcitonin: should it be measured systemically?]
Kim Luong Ba, Stephan Harbarth, Sebastian Carballo
Lancet (London, England)
|
June 26, 2022
Global burden of antimicrobial resistance: essential pieces of a global puzzle
Marlieke E A de Kraker, Stephan Harbarth
Intensive Care Medicine
|
September 18, 2014
De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU
Jean-Francois Timsit, Stephan Harbarth, Jean Carlet
Intensive Care Medicine
|
October 31, 2024
Skin decontamination to prevent infections in the intensive care unit
Marc Bonten, Bruno Martins Tomazini, Stephan Harbarth
Intensive Care Medicine
|
April 20, 2016
In 2035, will all bacteria be multidrug resistant? We are not sure
Kevin B Laupland, Etienne Ruppé, Stephan Harbarth
Intensive & Critical Care Nursing
|
September 6, 2021
In-hospital COVID-19 outbreak investigation: A practical approach to root cause analysis
Danielle Vuichard-Gysin, Mohamed Abbas, Stephan Harbarth
Current Opinion in Pharmacology
|
July 22, 2011
At least it won't hurt: the personal risks of antibiotic exposure
Andrew J Stewardson, Benedikt Huttner, Stephan Harbarth
Critical Care (London, England)
|
August 12, 2009
When once is not enough--further evidence of procalcitonin-guided antibiotic stewardship
Stephan Harbarth, Werner C Albrich, Beat Müller
Current Opinion in Infectious Diseases
|
July 3, 2008
Methicillin-resistant Staphylococcus aureus control in the 21st century: beyond the acute care hospital
Marta Banqué Navarro, Benedikt Huttner, Stephan Harbarth
Page
of 42
Search research articles
Search
Showing results (51-60 of 420) with videos related to
Sort By:
Page
of 42
Infection Control and Hospital Epidemiology
|
August 7, 2013
The environment and healthcare-acquired infections: why accurate reporting and evaluation of biological plausibility are important
Stephan Harbarth, Matthias Maiwald, Stephanie J Dancer
Revue Medicale Suisse
|
December 5, 2013
[Procalcitonin: should it be measured systemically?]
Kim Luong Ba, Stephan Harbarth, Sebastian Carballo
Lancet (London, England)
|
June 26, 2022
Global burden of antimicrobial resistance: essential pieces of a global puzzle
Marlieke E A de Kraker, Stephan Harbarth
Intensive Care Medicine
|
September 18, 2014
De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU
Jean-Francois Timsit, Stephan Harbarth, Jean Carlet
Intensive Care Medicine
|
October 31, 2024
Skin decontamination to prevent infections in the intensive care unit
Marc Bonten, Bruno Martins Tomazini, Stephan Harbarth
Intensive Care Medicine
|
April 20, 2016
In 2035, will all bacteria be multidrug resistant? We are not sure
Kevin B Laupland, Etienne Ruppé, Stephan Harbarth
Intensive & Critical Care Nursing
|
September 6, 2021
In-hospital COVID-19 outbreak investigation: A practical approach to root cause analysis
Danielle Vuichard-Gysin, Mohamed Abbas, Stephan Harbarth
Current Opinion in Pharmacology
|
July 22, 2011
At least it won't hurt: the personal risks of antibiotic exposure
Andrew J Stewardson, Benedikt Huttner, Stephan Harbarth
Critical Care (London, England)
|
August 12, 2009
When once is not enough--further evidence of procalcitonin-guided antibiotic stewardship
Stephan Harbarth, Werner C Albrich, Beat Müller
Current Opinion in Infectious Diseases
|
July 3, 2008
Methicillin-resistant Staphylococcus aureus control in the 21st century: beyond the acute care hospital
Marta Banqué Navarro, Benedikt Huttner, Stephan Harbarth
Page
of 42